Real-Time Quote
Quote | News | Chart | Details
MRK News & Analysis
The Early Allergy Season & Big Pharma: Sneezing Your Way To Profit
27 Mar 2012 EDT - CNBC.com
Page 2 of 3 | Prev Page | Next Page
Show Entire Article

“Other companies positioned to profit are the diversified pharma companies that own consumer products divisions — including Johnson & Johnson and Pfizer,” said Eade.

Miller Tabak Health Care Transformation Fund Manager Les Funtleyder shares the same view.

“We kind of had for drug companies not a great cold and flu season, because the weather was so wrong for it. But, we’ll make it back on the allergies,” said Les Funtleyder.

Merck, Johnson & Johnson, Sanofi and Pfizer make a big portion of the allergy drugs in the market — both prescription and over-the-counter. Of those, Funtleyder believes Merck, the maker of the antihistamine Claritan and nasal spray Afrin, will be the biggest winner.

Bottom line: You may not be breathing easier, but the world’s biggest pharmaceutical companies will be, this spring.

________________Disclosure: Miller Tabak Health Care Transformation Fund owns shares Of Merck and Johnson & Johnson.

________________

Stephanie is Squawk Box producer. Follow her on twitter @StephLandsman

Questions? Comments? Email us at NetNet@cnbc.com

Follow NetNet on Twitter @ twitter.com/CNBCnetnet

Page 2 of 3 | Prev Page | Next Page
Show Entire Article
MRK News & Analysis
Real-Time Quote
omniture pixel